http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007523925-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2005-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007523925-A |
| titleOfInvention | New therapeutic uses for a group of sulfated polysaccharides |
| abstract | The present invention is selected from the group consisting of inulin sulfate, gellan sulfate, pullulan sulfate, curdlan sulfate, sulfated alginic acid, laminarin sulfate and pectin sulfate for the manufacture of a medicament for the treatment or prevention of osteoarthritis in mammals The use of sulfated polysaccharides in the acid form or physiologically acceptable salts thereof. This sulfated polysaccharide is preferably inulin sulfate, more preferably inulin polysulfate sodium salt. The invention is also derived from a polysaccharide selected from the group consisting of inulin, gellan, pullulan, curdlan, alginic acid, laminarin and pectin for the manufacture of a medicament for the treatment or prevention of osteoarthritis in a mammal. The use of sulfated oligosaccharides. |
| priorityDate | 2004-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.